Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
26
Number of overlapping holdings
19.1%
% of XBI's 136 holdings also in IDNA
57.8%
% of IDNA's 49 holdings also in XBI
Overlap by Weight
Sector Drift (XBI minus IDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in IDNA |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 3.0% | 5.9% | 3.0% |
|
INCYTE CORP | 2.9% | 4.9% | 2.9% |
|
SAREPTA THERAPEUTICS INC | 2.7% | 4.2% | 2.7% |
|
REGENERON PHARMACEUTICALS | 1.7% | 3.1% | 1.7% |
|
BLUEPRINT MEDICINES CORP. | 1.7% | 1.5% | 1.5% |
Position Highlights (Non-Overlapping Exposures)
XBI Overweight Relative to IDNA
|
NATERA INC | 3.5% |
|
UNITED THERAPEUTICS CORP | 2.9% |
|
ADVENTRX PHARMACEUTICALS INC | 2.8% |
|
NEUROCRINE BIOSCIENCES INC | 2.8% |
|
INSMED INC | 2.6% |
|
VERTEX PHARMACEUTICALS INC | 2.6% |
|
EXACT SCIENCES CORP | 2.5% |
|
ALNYLAM PHARMACEUTICALS INC | 2.5% |
|
ABBVIE INC | 2.4% |
|
AMGEN INC | 2.2% |
XBI Underweight Relative to IDNA
|
EXELIXIS INC | -5.5% |
 |
BIONTECH SE SPONSORED ADR | -5.0% |
 |
BEIGENE, LTD. | -4.8% |
 |
ROCHE HOLDING LTD | -4.4% |
 |
TAKEDA PHARMACEUTICAL CO LTD | -4.2% |
 |
SANOFI-AVENTIS | -4.0% |
|
REVOLUTION MEDICINES, INC. | -3.5% |
 |
GSK PLC | -3.4% |
|
MERCK & CO. INC. | -3.3% |
|
ARCELLX, INC. | -3.2% |